John P. Butler - 29 Feb 2024 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
CEO and President, Director
Signature
/s/ Carolyn Rucci, attorney-in-fact for John P. Butler
Issuer symbol
AKBA
Transactions as of
29 Feb 2024
Net transactions value
-$73,581
Form type
4
Filing time
01 Mar 2024, 17:47:34 UTC
Previous filing
29 Feb 2024
Next filing
04 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale $73,581 -46,570 -2.2% $1.58 2,044,580 29 Feb 2024 Direct F1
holding AKBA Common Stock 100,000 29 Feb 2024 Held By John Butler GRAT November 2019
holding AKBA Common Stock 59,928 29 Feb 2024 Held by John Butler 2019 GRAT
holding AKBA Common Stock 100,000 29 Feb 2024 Held By Dorothy Butler GRAT November 2019
holding AKBA Common Stock 59,928 29 Feb 2024 Held by Dorothy Butler 2019 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.